Australia markets open in 2 hours 8 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
11,810.00+72.00 (+0.61%)
At close: 06:28PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 181.97B
Enterprise value 202.13B
Trailing P/E 37.40
Forward P/E 16.42
PEG ratio (5-yr expected) 0.86
Price/sales (ttm)4.90
Price/book (mrq)6.05
Enterprise value/revenue 5.40
Enterprise value/EBITDA 18.84

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 38.12%
S&P500 52-week change 332.65%
52-week high 313,388.00
52-week low 39,461.00
50-day moving average 312,473.76
200-day moving average 311,564.11

Share statistics

Avg vol (3-month) 31.85M
Avg vol (10-day) 32.41M
Shares outstanding 51.55B
Implied shares outstanding 61.55B
Float 81.54B
% held by insiders 10.04%
% held by institutions 150.97%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.34
Forward annual dividend yield 41.99%
Trailing annual dividend rate 32.97
Trailing annual dividend yield 30.03%
5-year average dividend yield 42.35
Payout ratio 470.08%
Dividend date 3N/A
Ex-dividend date 408 Aug 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 13.11%
Operating margin (ttm)22.42%

Management effectiveness

Return on assets (ttm)7.68%
Return on equity (ttm)16.74%

Income statement

Revenue (ttm)49.13B
Revenue per share (ttm)31.72
Quarterly revenue growth (yoy)13.30%
Gross profit (ttm)N/A
EBITDA 16.97B
Net income avi to common (ttm)6.44B
Diluted EPS (ttm)3.13
Quarterly earnings growth (yoy)6.00%

Balance sheet

Total cash (mrq)7.08B
Total cash per share (mrq)4.57
Total debt (mrq)33.65B
Total debt/equity (mrq)84.97%
Current ratio (mrq)0.89
Book value per share (mrq)25.49

Cash flow statement

Operating cash flow (ttm)11.06B
Levered free cash flow (ttm)9.82B